BCM
TMDX icon

Bayesian Capital Management’s Transmedics TMDX Stock Holding History

Bayesian Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,800
Closed -$314K – 511
2025
Q3 		$314K Sell
2,800
-3,400
-55% -$398K 0.06% 375
2025
Q2 		$831K Sell
6,200
-5,655
-48% -$621K 0.13% 208
2025
Q1 		$798K Buy
+11,855
New +$815K 0.13% 211
2024
Q3 		– Sell
-2,000
Closed -$301K – 1037
2024
Q2 		$301K Buy
+2,000
New +$240K 0.03% 506
2024
Q1 		– Sell
-28,935
Closed -$2.28M – 1120
2023
Q4 		$2.28M Buy
28,935
+8,500
+42% +$513K 0.24% 112
2023
Q3 		$1.12M Buy
20,435
+13,200
+182% +$950K 0.13% 200
2023
Q2 		$608K Sell
7,235
-2,800
-28% -$214K 0.07% 365
2023
Q1 		$760K Buy
10,035
+900
+10% +$62.2K 0.09% 283
2022
Q4 		$564K Buy
+9,135
New +$486K 0.08% 318

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Bayesian Capital Management's TMDX Position: Q4 2025 in Review

Bayesian Capital Management sold out of Transmedics (TMDX) in Q4 2025, closing a stake of 2,800 shares — an estimated $314K sold.

Bayesian Capital Management first reported a position in TMDX in Q4 2022 and held it in 9 quarters. The position peaked at $2.28M in Q4 2023. 429 funds tracked by Wall St. Rank hold TMDX as of Q4 2025.

  • Bayesian Capital Management reported no remaining Transmedics position as of Q4 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 2,800 Transmedics shares in Q4 2025, an estimated $314K.
  • Bayesian Capital Management first reported a position in Transmedics in Q4 2022 and held it in 9 quarters.
  • Bayesian Capital Management's Transmedics position peaked at $2.28M in Q4 2023.
  • 429 funds tracked by Wall St. Rank held Transmedics as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.